Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase 3 2Phase 1/2 2Phase 4 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 2Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Anemia 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pain 1Neutropenia 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Hypothyroidism 1Human Papillomavirus-Related Cervical Carcinoma 1Hepatitis C, Chronic 1Hepatitis C 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fibrosis 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Diabetes Mellitus 1

Interventions

Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NIH × Drug-Related Side Effects and Adverse Reactions × Clear all
NCT00003252 2013-03-26

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

National Cancer Institute (NCI)

Phase 4 Completed

Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡